NewLeaf Symbiotics
Categories
Founded
2012
Leadership
- Brent Smith, CEO
- Steve Kahn, Co-Founder
Headquarters
St Louis, MO
Website
S2G North Star Interim Outcomes
- Increased availability, accessibility, and/or affordability of healthier foods and nutrition-based solutions Jump to footnote 1
NewLeaf Symbiotics is a biological technology provider.
The company is a pioneer and global leader of Pink-Pigmented Facultative Methylotrophs (PPFMs) and methanotrophs, a closely related microbe. Ranging from row crops to specialty operations, NewLeaf is dedicated to a science-led, performance-driven and data-backed approach that delivers results to its partners and the growers they support.
Open Positions
-
NewLeaf SymbioticsSkopje, Macedonia (FYROM)
-
NewLeaf Symbiotics
Software Engineer III
Skopje, Macedonia (FYROM) -
NewLeaf Symbiotics
Quality Engineer III — (2 available roles)
Macedonia (FYROM) -
NewLeaf Symbiotics
Industry Solution Director — Defence Sector
United Kingdom -
NewLeaf Symbiotics
Technical Data Archival Consultant
Melbourne, VIC, Australia
Insights
News
AgFunder News
NewLeaf Raises $45M in Series D Round
Footnotes
S2G North Star Interim Outcomes reflect areas of strategic alignment with our long-term impact goals. These outcomes are intended to illustrate the types of non-financial progress S2G seeks to support across its portfolio and do not represent company-specific metrics or outcomes. They are not a reflection of investment performance, actual or realized returns, or future financial results.